Role of surgical resection for multiple hepatocellular carcinomas

Table 1 Clinical characteristics of the surgical resection patients vs the transarterial chemoembolization patients

Variable	Surgical resection(n = 36)	TACE(n = 107)	P value
Age (yr)	54.3 ± 8.6	61.2 ± 9.3	< 0.001
Gender (male:female)	34:2	86:21	0.047
Platelet (k/mm3)	153.4 ± 53.9	121.0 ± 51.8	0.002
Albumin (g/dL)	4.05 ± 0.50	3.93 ± 0.48	0.203
ALT (IU/L)	36.4 ± 15.8	59.0 ± 40.4	0.001
AST (IU/L)	41.2 ± 25.8	53.2 ± 44.7	0.130
HBsAg	28 (77.8)	67 (62.6)	0.099
Clinical liver cirrhosis	20 (55.6)	100 (93.5)	< 0.001
Tumor number			0.549
2	30 (83.3)	90 (84.1)
3	6 (16.7)	17 (15.9)
Main tumor size (cm)			0.005
< 3	19 (52.8)	17 (47.2)
≥ 3	29 (27.1)	78 (72.9)
AFP > 1000 IU/mL	2 (5.6)	8 (7.5)	0.696

Data are expressed as absolute n (%) or mean ± SD. M: Male; F: Female; TACE: Transarterial chemoembolization; ALT: Alanine aminotransferase (reference range, 5-46 IU/L); AST: Aspartate aminotransferase (reference range, 13-34 IU/L); HBsAg: Hepatitis B surface antigen; AFP: α-fetoprotein.